California, Fda | featured news

Researchers announced Tuesday the beginning of a FDA-approved clinical trial that uses umbilical cord blood stem cells to ‘cure’ autism. Dr. Michael Chez, director of pediatric neurology at Sutter Neuroscience Institute in Sacramento, Calif., said he and his colleagues have been processing the trial for more than a year now, and they have high hopes it will succeed.

A California company has recalled hazelnuts sold in bulk, individual containers and as part of mixed-nut packages sold throughout the United States and Canada due to possible E. coli contamination, the U.S. Food and Drug Administration announced.